Impact of FOLFIRINOX compared with gemcitabine on quality of life in patients with metastatic pancreatic cancer: results from the PRODIGE 4/ACCORD 11 randomized trial

ANNÉE

2013

AUTEURS

Gourgou-Bourgade S, Bascoul-Mollevi C, Desseigne F, Ychou M, Bouché O, Guimbaud R, Bécouarn Y, Adenis A, Raoul JL, Boige V, Bérille J, Conroy T

CONGRÈS/REVUE

J Clin Oncol

ÉTUDE

Localisation

LIEN PUBLICATIONS ASSOCIÉES